Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079709 | SCV000111592 | benign | not specified | 2012-11-07 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000079709 | SCV000151200 | benign | not specified | 2015-02-10 | criteria provided, single submitter | clinical testing | |
Claritas Genomics | RCV000079709 | SCV000222860 | likely benign | not specified | 2013-09-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000079709 | SCV000250353 | benign | not specified | 2014-06-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001084164 | SCV000261525 | benign | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079709 | SCV000306626 | benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV000205572 | SCV000603738 | benign | not provided | 2023-11-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004019549 | SCV000738350 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-04-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000205572 | SCV001143940 | benign | not provided | 2019-07-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000079709 | SCV003929158 | benign | not specified | 2023-04-10 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000079709 | SCV001739804 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000079709 | SCV001808801 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000079709 | SCV001970049 | benign | not specified | no assertion criteria provided | clinical testing |